Low dose rituximab efficiently clears circulating CLL cells and maintains sensitivity to antibody dependent cellular cytotoxicity (ADCP)

Clive Zent, Clare Heffernan,Charles Chu, Jennifer Bruno, Christine Herne,Andrea Baran,Ronald Taylor,Paul Barr, Michael Elliott

LEUKEMIA & LYMPHOMA(2023)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要